GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige BioPharma Ltd (XKRX:950210) » Definitions » Policy Acquisition Expense

Prestige BioPharma (XKRX:950210) Policy Acquisition Expense


View and export this data going back to 2021. Start your Free Trial

What is Prestige BioPharma Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Prestige BioPharma Business Description

Traded in Other Exchanges
N/A
Address
2 Science Park Drive No. 04-13/14, Ascent Tower B, Singapore Science Park, Singapore, SGP, 118222
Prestige BioPharma Ltd is a biopharmaceutical company. The company is focused on the development of biosimilars and new antibody therapeutics. It focuses on oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis.